The Performance of Digital Technologies for Measuring Tuberculosis Medication Adherence: A Systematic Review

Miranda Zary,Mona Salaheldin Mohamed,Cedric Kafie,Chimweta Ian Chilala,Shruti Bahukudumbi,Nicola Foster,Genevieve Gore,Katherine Fielding,Ramnath Subbaraman,Kevin Schwartzman
DOI: https://doi.org/10.1101/2024.05.24.24307886
2024-05-24
Abstract:: Digital adherence technologies (DATs), such as phone-based technologies, and digital pillboxes, can provide more person-centric approaches to support tuberculosis (TB) medication adherence. We synthesized evidence addressing the performance of DATs for measuring tuberculosis medication adherence. : We conducted a systematic review (PROSPERO - CRD42022313526) which identified relevant published literature from January 2000 through April 2023 in five databases, and pertinent preprints. Studies reporting quantitative data on the performance of DATs for measuring adherence to medications for TB disease or infection, against a reference standard, with at least 20 participants using the DAT were included. Study characteristics and performance outcomes (e.g., sensitivity, specificity, positive and negative predictive values) were extracted. Article quality was assessed using the QUADAS-2 tool for diagnostic accuracy studies. : Of 5692 studies initially identified by our systematic search, 13 met our inclusion criteria. These studies addressed the performance of medication sleeves with phone calls [branded as 99DDOTS; N=4], digital pillboxes [N=5], ingestible sensors [N=2], artificial intelligence-based video observed therapy [N=1], and multifunctional mobile applications [N=1]. All but one involved persons with TB disease. For medication sleeves with phone calls, compared to urine analysis, reported sensitivity and specificity was 70-94% and 0-61%, respectively. For digital pillboxes, compared to pill count, reported sensitivity and specificity was 25-99% and 69-100%, respectively. For ingestible sensors, the sensitivity of dose detection was greater than or equal to 95% in comparison to directly observed ingestion. Participant selection was the most frequent potential source of bias across articles. : Limited available data suggest suboptimal and variable performance of DATs for dose monitoring, with significant evidence gaps, notably in real-world programmatic settings. Future research should aim to improve understanding of the relationships of specific technologies, settings, user characteristics, and user engagement with DAT performance, and should measure and report performance in a more standardized manner.
What problem does this paper attempt to address?